prikaz prve stranice dokumenta Novi lijekovi u kemoterapiji tumora
  Download
PDF 197.98 KB
undergraduate thesis
Novi lijekovi u kemoterapiji tumora
Zagreb: University of Zagreb, Faculty of Science, 2010. urn:nbn:hr:217:344172
Hanžić, Nikolina
University of Zagreb
Faculty of Science
Department of Biology

Institutional repository: Repository of the Faculty of Science

Cite this document

Hanžić, N. (2010). Novi lijekovi u kemoterapiji tumora (Undergraduate thesis). Zagreb: University of Zagreb, Faculty of Science. Retrieved from https://urn.nsk.hr/urn:nbn:hr:217:344172

Hanžić, Nikolina. "Novi lijekovi u kemoterapiji tumora." Undergraduate thesis, University of Zagreb, Faculty of Science, 2010. https://urn.nsk.hr/urn:nbn:hr:217:344172

Hanžić, Nikolina. "Novi lijekovi u kemoterapiji tumora." Undergraduate thesis, University of Zagreb, Faculty of Science, 2010. https://urn.nsk.hr/urn:nbn:hr:217:344172

Hanžić, N. (2010). 'Novi lijekovi u kemoterapiji tumora', Undergraduate thesis, University of Zagreb, Faculty of Science, accessed 23 December 2024, https://urn.nsk.hr/urn:nbn:hr:217:344172

Hanžić N. Novi lijekovi u kemoterapiji tumora [Undergraduate thesis]. Zagreb: University of Zagreb, Faculty of Science; 2010 [cited 2024 December 23] Available at: https://urn.nsk.hr/urn:nbn:hr:217:344172

N. Hanžić, "Novi lijekovi u kemoterapiji tumora", Undergraduate thesis, University of Zagreb, Faculty of Science, Zagreb, 2010. Available at: https://urn.nsk.hr/urn:nbn:hr:217:344172

Metadata
TitleNovi lijekovi u kemoterapiji tumora
Title (english)New drugs in cancer chemotherapy
AuthorNikolina Hanžić
MentorNada Oršolić (mentor)
GranterUniversity of Zagreb
Faculty of Science
(Department of Biology)
Zagreb
Defense date and country2010, Croatia
Scientific / art field,
discipline and subdiscipline		NATURAL SCIENCES
Biology
Abstract
Tumorske stanice su osjetljivije od normalnih stanica na kemoterapijske lijekove. Cilj lijekova koji se koriste u kemoterapiji tumora je izazivanje apoptoze tumorskih stanica. U ovom radu izložen je pregled antitumorskih lijekova. Postoje dvije vrste antitumorskih lijekova: pametni lijekovi i genski lijekovi. Pametni lijekovi usmjereni su na specifične signalne puteve odgovorne za rast tumora te djeluju na specifične antigene, faktore rasta, receptore i ostale molekule u signalnim putevima od interesa. S druge strane, genski lijekovi su usmjereni na ciljanje molekule DNA.
Abstract (english)
Cancer cells are more vulnerable than normal cells to the effect of chemotherapy agents. Agents in cancer therapies are aimed at inducing apoptosis. In this work, a short review of the most important anticancer drugs, has been presented. There are two types of anticancer drugs: smart drugs and gene drugs. So-called “smart drugs” are directed towards specific signalling pathways responsible for tumor growth and target specific antigen, growth factor, receptor or other molecule in the signalling pathway of interest. On the other hand, so-called ‘‘gene drugs’’ are directed towards targeting the DNA molecule.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:217:344172
Study programmeTitle: Molecular Biology
Study programme type: university
Study level: undergraduate
Academic / professional title: sveučilišni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) molekularne biologije (sveučilišni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) molekularne biologije)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2018-03-23 12:04:11